Jane Huang
President bij PRELUDE THERAPEUTICS INCORPORATED
Vermogen: 243 246 $ op 31-03-2024
Profiel
Dr. Jane E. Huang, MD, is Chief Medical Officer-Hematology bij BeiGene Ltd. Dr. Huang was voorheen werkzaam als Vice President & Head-Clinical Development bij Acerta Pharma BV en als Group Medical Director bij Genentech, Inc. Zij behaalde haar doctoraal aan de Stanford University en haar doctoraat aan de Washington University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-04-2024 | 51 287 ( 0.09% ) | 243 100 $ | 31-03-2024 | |
BEIGENE LTD
0.00% | 17-04-2023 | 12 ( 0.00% ) | 146 $ | 31-03-2024 |
| 07-06-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Jane Huang
| Bedrijven | Functie | Begin |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Director/Board Member | 09-06-2021 |
| PRELUDE THERAPEUTICS INCORPORATED | President | 04-04-2022 |
858 Therapeutics, Inc.
 858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Director/Board Member | 05-04-2022 |
Eerdere bekende functies van Jane Huang
| Bedrijven | Functie | Einde |
|---|---|---|
| BEIGENE, LTD. | Chief Tech/Sci/R&D Officer | 03-04-2022 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Corporate Officer/Principal | 01-09-2016 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-03-2015 |
Opleiding van Jane Huang
| Stanford University | Undergraduate Degree |
| Washington University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BEIGENE, LTD. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| PROTARA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Health Technology |
